Enveric Biosciences (ENVB) Non Operating Income (2016 - 2026)
Enveric Biosciences (ENVB) posted Non Operating Income of -$292.00 for Q2 2026, compared with -$132.00 a year earlier.
Powered by 
Analysis
Enveric Biosciences (ENVB) Non Operating Income (2016 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non Operating Income at Enveric Biosciences was -$569.00; for FY2025, it was $2,461, down 96.3% from FY2024.
- In prior years, Enveric Biosciences' Non Operating Income was $66,209 in FY2024, -$814,379 in FY2023, $7.46 million in FY2022 (-9.0%) and $8.19 million in FY2021.
- Quarterly Non Operating Income has run from a low of -$1.03 million in Q4 2023 to a high of $3.18 million in Q3 2022 over five years.
- The strongest year-over-year quarter for Non Operating Income in the past five years was Q3 2022, with growth of 295.0%; the weakest was Q1 2022, with a decline of 92.3%.
- According to Business Quant data, Non Operating Income for the three prior quarters was -$303.00 (Q1 2026), -$248.00 (Q4 2025) and $274.00 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Enveric Biosciences | 5.86 Mn | -15.78 Mn | - | -292.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -292.00 |
| Mar 31, 2026 | -303.00 |
| Dec 31, 2025 | -248.00 |
| Sep 30, 2025 | 274.00 |
| Jun 30, 2025 | -132.00 |
| Mar 31, 2025 | 2,567.00 |
| Dec 31, 2024 | 26,379.00 |
| Sep 30, 2024 | -840.00 |
| Jun 30, 2024 | 18,537.00 |
| Mar 31, 2024 | 22,133.00 |
| Dec 31, 2023 | -1.03 Mn |
| Sep 30, 2023 | 632,774.00 |
| Jun 30, 2023 | -601,046.00 |
| Mar 31, 2023 | 183,151.00 |
| Dec 31, 2022 | 2.09 Mn |
| Sep 30, 2022 | 3.18 Mn |
| Jun 30, 2022 | 1.92 Mn |
| Mar 31, 2022 | 271,831.00 |
| Dec 31, 2021 | 1.42 Mn |
| Sep 30, 2021 | 804,463.00 |
API Access
Enveric Biosciences Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();